We’ve moved our Avian Vaccine Services office headquarters from North Franklin, CT to neighboring Norwich, CT. We look forward to serving our many loyal customers at our new site.
Explore our recently expanded Safety Assessment portfolio with ease. Our new navigation structure uses drop-down and fly-out menus to give you quicker access to information.
We are excited to announce the addition of Blue Stream Laboratories to our growing Charles River team. The expertise of the Blue Stream organization will enhance our analytical capabilities, providing you with a complete solution for your biologic and biosimilar development.
As a result of Charles River’s continued commitment to emerging drug discovery technologies, a strategic collaboration has been established with caprotec bioanalytics, GmbH, to offer their proprietary protein capture technology for phenotypic screening target deconvolution.
During the finalization of the OECD 443 guideline, Extended One-generation Reproductive Toxicity Study (EOGRTS), scientists at our facilities in Den Bosch, Lyon and Ashland were asked to work on the implementation of this study type and to harmonize the study designs at the sites.
The Single Mouse Trial (SMT) format for in vivo patient-derived xenograft (PDX) studies addresses the need for more cost-effective compound testing in the larger, more diverse tumor populations that can be targeted using our vast portfolio of highly characterized models.
On May 14, 2016, Charles River sponsored Great Strides®, a walk supporting the Cystic Fibrosis Foundation. The event brought more than 950 participants to the Cleveland Zoo and raised more than $270,000 to support the search for a cure.
In addition to an exhibit, Charles River scientists presented three posters and moderated a presentation during this year's conference.
Continuous health surveillance is a critical task in resident animal colony management. Rapid, trusted results provide the information you need to make go/no-go decisions regarding contamination and to avoid the consequences of a biosecurity breach. Charles River has always provided timely, reliable data on every health monitoring sample we process. Our recent laboratory improvements will deliver even greater efficiency and value to our clients.
Charles River’s commitment to the 3Rs continues with Curiox miniaturized assays that can be coupled with Luminex® technology. Multiplex panels currently being developed and offered by Charles River include the simultaneous measurement of cytokines, chemokines, hormones and metabolic biomarkers, bone markers, cardiac and muscle injury markers, and renal toxicity biomarkers.